Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients
Status:
Completed
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and efficacy of Sofosbuvir
containing regimens in treatment-naive or treatment-experienced patients with HCV genotypes 2
infection.
Phase:
Phase 4
Details
Lead Sponsor:
Humanity & Healthy GI and Liver Centre Humanity and Health Research Centre